Evidence map›Paper›PMID 27616161›Full record

ArticleScientific reports2016

Osteogenic differentiation of preosteoblasts on a hemostatic gelatin sponge.

Zong-Keng Kuo, Po-Liang Lai, Elsie Khai-Woon Toh, Cheng-Hsi Weng, Hsiang-Wen Tseng, Pei-Zen Chang, Chih-Chen Chen, Chao-Min Cheng

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Zong-Keng KuoInstitute of Nanoengineering and Microsystems, National Tsing Hua University, Hsinchu City 30013, Taiwan.
Po-Liang LaiDepartment of Orthopedic Surgery, Bone and Joint Research Center, Chang Gung Memorial Hospital, College of Medicine, Chang Gung University, Taoyuan 33305, Taiwan.
Elsie Khai-Woon TohDepartment of Orthopedic Surgery, Bone and Joint Research Center, Chang Gung Memorial Hospital, College of Medicine, Chang Gung University, Taoyuan 33305, Taiwan.
Cheng-Hsi WengInstitute of Applied Mechanics, National Taiwan University, Taipei City 10617, Taiwan.
Hsiang-Wen TsengPharmacodynamics Technology Department, Center of Excellence for Drug Development, Biomedical Technology and Device Research Labs, Industrial Technology Research Institute, Hsinchu City 30011, Taiwan.
Pei-Zen ChangInstitute of Applied Mechanics, National Taiwan University, Taipei City 10617, Taiwan.
Chih-Chen ChenInstitute of Nanoengineering and Microsystems, National Tsing Hua University, Hsinchu City 30013, Taiwan.
Chao-Min ChengInstitute of Biomedical Engineering, National Tsing Hua University, Hsinchu City 30013, Taiwan.
National Tsing Hua University · TWChang Gung Memorial Hospital · TWNational Taiwan University · TWIndustrial Technology Research Institute · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone tissue engineering provides many advantages for repairing skeletal defects. Although many different kinds of biomaterials have been used for bone tissue engineering, safety issues must be considered when using them in a clinical setting. In this study, we examined the effects of using a common clinical item, a hemostatic gelatin sponge, as a scaffold for bone tissue engineering. The use of such a clinically acceptable item may hasten the translational lag from laboratory to clinical studies. We performed both degradation and biocompatibility studies on the hemostatic gelatin sponge, and cultured preosteoblasts within the sponge scaffold to demonstrate its osteogenic differentiation potential. In degradation assays, the gelatin sponge demonstrated good stability after being immersed in PBS for 8 weeks (losing only about 10% of its net weight and about 54% decrease of mechanical strength), but pepsin and collagenases readily biodegraded it. The gelatin sponge demonstrated good biocompatibility to preosteoblasts as demonstrated by MTT assay, confocal microscopy, and scanning electron microscopy. Furthermore, osteogenic differentiation and the migration of preosteoblasts, elevated alkaline phosphatase activity, and in vitro mineralization were observed within the scaffold structure. Each of these results indicates that the hemostatic gelatin sponge is a suitable scaffold for bone tissue engineering.

Indexed as

Alkaline PhosphataseAnimalsCell DifferentiationCell LineCell ProliferationGelatinHemostaticsMiceOsteoblastsOsteogenesisTissue EngineeringTissue ScaffoldsAlkaline PhosphataseGelatinHemostatics

Identifiers

PMID27616161
PMCPMC5018723
OpenAlexW2520772360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.